Skip to main content

S32 — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

101
Companies
$4.4B
Total invested
$54.2M
Avg. check
36
Industries
Biotechnology 12Artificial Intelligence (AI) 9Health Care 7Medical 6Therapeutics 5Precision Medicine 4+30 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 101
ScienceIO
August 2023

ScienceIO develops a biomedical language platform to transform complex medical text into usable data and actionable insights.

Analytics · Boston$8.0M Series A
Spectral
August 2022

Spectral is a protocol for programmable creditworthiness.

Blockchain · New Rochelle$23.0M Venture - Series Unknown
BigHat Biosciences
July 2022

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Artificial Intelligence (AI) · San Mateo$75.0M Series B
Owl AI
June 2025

Owl AI is a sports technology company that uses artificial intelligence to improve performance analytics and decision-making in sports.

Analytics · San Francisco$11.0M Seed
AltPep
June 2023

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Biotechnology · Seattle$52.9M Series B
Delve Bio
June 2023

Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.

Biotechnology · San Francisco$35.0M Series A
Inductive Bio
May 2025

Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.

Biotechnology · San Francisco$25.0M Series A
Relay Therapeutics
May 2026

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Biotechnology · Cambridge$275.0M Post-IPO Equity
MOMA Therapeutics
May 2022

MOMA Therapeutics operates as a biotechnology company.

Biotechnology · Cambridge$150.0M Series B
Function Oncology
April 2023

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

Biotechnology · San Diego$28.0M Series A
Satellite Bio
March 2022

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Biopharma · Newton$82.5M Series A
Celsius Therapeutics
March 2022

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Biotechnology · Cambridge$83.0M Series B
Autoscience
March 2026

Autoscience uses science and tech to improve vehicle automation, safety, and performance.

San Mateo$14.0M Seed
RunSybil
March 2026

RunSybil is an AI-powered offensive security platform designed to continuously test applications and infrastructure for vulnerabilities.

Artificial Intelligence (AI) · San Francisco$40.0M Seed
MedCrypt
February 2025

MedCrypt is a medical device company that provides data security as a service to medical device OEMs.

Health Care · Solana Beach$8.3M Debt Financing
Phaidra
October 2025

Phaidra provides AI and ML solutions to accelerate performance in large-scale industries.

Artificial Intelligence (AI) · Seattle$50.0M Series B
Character Biosciences
September 2025

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

Artificial Intelligence (AI) · Jersey City$17.0M Series B
Endor Labs
April 2025

Endor Labs secures software supply chains with advanced tools for open-source risk, compliance, and developer productivity.

Cyber Security · Palo Alto$93.0M Series B
Octave
March 2025

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Biotechnology · Menlo Park$31.8M Series C
Sola Security
March 2025

Sola Security provides a self-serve cybersecurity platform that enables organizations to build, customize, and manage security tools.

Artificial Intelligence (AI) · Tel Aviv-jaffa$30.0M Seed
Network Bio
February 2025

Network Bio's biomedical data for AI-enabled precision medicine

Bioinformatics · New York$17.0M Seed
Meatable
November 2024

Meatable is a food production company that produces guilt-free meat.

Food and Beverage · LeidenVenture - Series Unknown
TollBit
October 2024

TollBit is a content monetization platform that allows AI bots and data scrapers to pay for content instead of scraping data from websites.

Artificial Intelligence (AI) · New York$24.0M Series A
Basecamp Research
October 2024

Basecamp Research leverages their unprecedented knowledge of the natural world to create better medicines, better food and better products

Artificial Intelligence (AI) · London$60.0M Series B

Where S32 invests

Biotechnology12
Artificial Intelligence (AI)9
Health Care7
Medical6
Therapeutics5
Precision Medicine4

About S32's portfolio

How many companies has S32 invested in?

S32 has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does S32 invest in?

S32's top investment sectors include Biotechnology, Artificial Intelligence (AI), Health Care, Medical, Therapeutics. The firm invests across 36 different industry categories.

What is S32's largest investment?

Among tracked funding rounds, Relay Therapeutics received $275.0M in a Post-IPO Equity round. S32's total known invested capital is $4.4B.

What is the average investment size for S32?

S32's average investment size is $54.2M across its portfolio of 101 companies.

What are S32's most recent investments?

Recent S32 portfolio additions include ScienceIO, Spectral, BigHat Biosciences, Owl AI, AltPep. These companies were founded in 2020 or later.

Reach the founders behind these 101 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →